(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
10 day averaged volume of Biomarin Pharmaceutical is 1860370
Date | Daily Closing Price | Open | High | Low | Volume |
05 Tue Aug 2025 | 61.93 | 63.33 | 63.97 | 58.72 | 3.757 times |
01 Fri Aug 2025 | 58.14 | 57.50 | 58.19 | 56.52 | 2.052 times |
31 Thu Jul 2025 | 57.85 | 58.24 | 59.01 | 57.36 | 1.25 times |
30 Wed Jul 2025 | 58.81 | 58.68 | 59.62 | 58.26 | 1.367 times |
29 Tue Jul 2025 | 58.23 | 58.07 | 58.65 | 57.58 | 0.765 times |
28 Mon Jul 2025 | 58.14 | 59.13 | 59.40 | 58.11 | 0.621 times |
25 Fri Jul 2025 | 59.01 | 60.06 | 60.09 | 58.87 | 0.669 times |
24 Thu Jul 2025 | 59.76 | 59.58 | 60.29 | 59.26 | 1.01 times |
23 Wed Jul 2025 | 59.67 | 59.56 | 60.43 | 59.15 | 0.742 times |
22 Tue Jul 2025 | 59.20 | 56.81 | 59.22 | 56.81 | 0.954 times |
Stock of Biomarin Pharmaceutical (BMRN) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 61.1, for a target of 59.7 or 58.54
Share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Target | 52.93 |
Downside Target | 56.48 |
Downside Target | 58.59 |
Downside Target | 59.62 |
Downside Target | 59.98 |
Downside Target | 60.43 |
Upside Target | 63.97 |
Upside Target | 65.40 |
Upside Target | 70.63 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Intraday Target | 59.11 |
Downside Intraday Target | 56.29 |
Upside Intraday Target | 64.36 |
Upside Intraday Target | 66.79 |
Downside Intraday Target | 61.54 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Weekly Closing Price | Open | High | Low | Volume |
05 Tue Aug 2025 | 61.93 | 63.33 | 63.97 | 58.72 | 0.621 times |
01 Fri Aug 2025 | 58.14 | 59.13 | 59.62 | 56.52 | 1.535 times |
25 Fri Jul 2025 | 59.01 | 57.28 | 60.43 | 56.48 | 1.044 times |
18 Fri Jul 2025 | 57.29 | 58.06 | 59.35 | 56.52 | 0.656 times |
11 Fri Jul 2025 | 58.10 | 56.97 | 59.98 | 56.76 | 1.223 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Monthly Closing Price | Open | High | Low | Volume |
05 Tue Aug 2025 | 61.93 | 57.50 | 63.97 | 56.52 | 0.272 times |
31 Thu Jul 2025 | 57.85 | 54.64 | 60.43 | 54.63 | 0.938 times |
30 Mon Jun 2025 | 54.97 | 57.99 | 58.59 | 53.72 | 0.925 times |
30 Fri May 2025 | 58.07 | 63.20 | 65.40 | 57.11 | 1.271 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 59.6 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 59.6 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.